Abstract:Introduction: Alzheimer’s disease (AD) is a progressive and incurable neurodegenerative condition that affects millions of people worldwide. The search for effective treatments for this disease has long been a priority in healthcare. In recent years, interest in the use of cannabidiol (CBD), one of the compounds found in the Cannabis sativa plant, has grown due to its potential therapeutic properties. A literature review was conducted covering searches in electronic databases, such as PubMed, SciELO and LILACS, with the aim of gathering as much information on the selected theme. Descriptors such as “Alzheimer”, “Cannabidiol”, “Treatment” and “CBD” were used, combined with the Boolean operator AND. The selection of articles considered the date of recent publication, limited to the last 10 years, as well as research related to the same theme and articles in Portuguese or foreign language (English). Duplicate articles, those that did not fit the proposed theme, as well as theses, monographs and dissertations were excluded. It was observed that CBD has characteristics often associated with Alzheimer’s therapy, such as anti-inflammatory, neuroprotective properties and mild adverse effects. The results indicated that the use of CBD in Alzheimer’s treatment shows promising potential. CBD was found to be especially beneficial for patients with neurodegenerative diseases. In conclusion, Cannabis is a viable substance given its promising therapeutic properties in the context of neuronal health, and its approach shows positive results in terms of recovery, symptomatologic improvement, and quality of life for patients affected by Alzheimer’s. Despite limitations and the need for further studies, results to date suggest that CBD may represent a promising option for symptomatic treatment and possibly even for modifying disease progression. However, it is critical to conduct larger-scale controlled clinical trials to confirm these findings and establish clear guidelines for its clinical use. These results may provide input for the development of future research and promising therapeutic strategies for Alzheimer’s disease.

Exploring Cannabinoids with Enhanced Binding Affinity for Targeting the Expanded Endocannabinoid System: A Promising Therapeutic Strategy for Alzheimer's Disease Treatment

A Comprehensive Exploration of the Multifaceted Neuroprotective Role of Cannabinoids in Alzheimer's Disease across a Decade of Research

Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer's Disease

Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer's Disease

A combination of Δ9-tetrahydrocannabinol and cannabidiol modulates glutamate dynamics in the hippocampus of an animal model of Alzheimer's disease

Activation of CB2 Receptor System Restores Cognitive Capacity and Hippocampal Sox2 Expression in a Transgenic Mouse Model of Alzheimer's Disease

Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease

Cannabinerol Prevents Endoplasmic Reticulum and Mitochondria Dysfunctions in an In Vitro Model of Alzheimer's Disease: A Network-Based Transcriptomic Analysis

Boosting Acetylcholine Signaling by Cannabidiol in a Murine Model of Alzheimer's Disease

Cannabidiol Ameliorates Cognitive Decline in 5xfad Mouse Model of Alzheimer's Disease Through Potentiating the Function of Extrasynaptic Glycine Receptors

CANNABIDIOL AS A NOVEL THERAPY FOR ALZHEIMER’S DISEASE

Therapeutic treatment with the anti-inflammatory drug candidate MW151 may partially reduce memory impairment and normalizes hippocampal metabolic markers in a mouse model of comorbid amyloid and vascular pathology

Cannabinoid pharmacology and its therapeutic uses in Alzheimer’s disease

Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer's Disease

In-Silico discovery of 17alpha-hydroxywithanolide-D as potential neuroprotective allosteric modulator of NMDA receptor targeting Alzheimer's disease

Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo

Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer's disease

Cannabidiol Ameliorates Cognitive Decline in 5×FAD Mouse Model of Alzheimer’s Disease Through Potentiating the Function of Extrasynaptic Glycine Receptors

Cannabidiol ameliorates cognitive decline in 5×FAD mouse model of Alzheimer's disease through potentiating the function of extrasynaptic glycine receptors

Discovery of Drug Lead Compounds for Anti-Alzheimer's Disease on the Basis of Synaptic Plasticity.

Design, Synthesis, and Biological Evaluation of Novel Chromanone Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease